Pharmapex® Group - Promoting People's Health throughout the World
Headquartered in the U.S., Pharmapex is a multinational group of companies leading the way in manufacturing and supply of a broad range of health-related products around the world. These companies offer one of the most diverse and unique portfolios of products in the healthcare industry that is provided to clientele after years of research and development efforts. All the manufactured products meet or exceed the stringent U.S. FDA requirements and comply with American standards for manufacturing procedures. Pharmapex's global capabilities include direct and indirect sales by its companies in four continents, and an extensive worldwide service network.
Whether it's analgesics or patented supplements, feed premixes or diagnostic kits, generics or biosimilars, we make products that help people live healthier lives.
Deferoxamine Mesylate Market to Witness Robust Expansion by 2029 with Teva api, Chengdu Easton Biopharmaceuticals, Pharmapex Group
The Deferoxamine Mesylate Report is a unique record that gives a total judgment of the market in terms of
future patterns, development factors, creation volume, CAGR estimation, net revenue, cost, and industry-approved market data.
Pharmapex's novel mastitis treatment offers hope to world farmers
Efficient feed-based mastitis treatment boosts livestock health with a unique microencapsulated technology.
FDA approves Farxiga to treat type 2 diabetes
The U.S. FDA today approved Farxiga (dapaglifozin) tablets to improve glycemic control, along with diet and exercise, in adults with type 2 diabetes.
© , Pharmapex USA, A member of Apex Group of Companies, All Rights Reserved.